CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE

CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE Struktur
1421676-91-6
CAS-Nr.
1421676-91-6
Englisch Name:
CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE
Synonyma:
CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE;cis-2-Bocamino-cyclopropanecarboxylic acid ethyl ester;ethyl cis-2-(tert-butoxycarbonylamino)cyclopropanecarboxylate;Cyclopropanecarboxylic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester, (1R,2S)-rel-
CBNumber:
CB03543634
Summenformel:
C11H19NO4
Molgewicht:
229.27
MOL-Datei:
1421676-91-6.mol

CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE Eigenschaften

Sicherheit

CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE Chemische Eigenschaften,Einsatz,Produktion Methoden

CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 9)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Labnetwork lnc.
+86-27-50766799 +8618062016861
contact@labnetwork.com China 19994 58
Nantong MYBio-pharm. Co., Ltd. 0513-66921823 18662920231
sales@minyanmedical.com China 3339 58
JW & Y Pharmlab Co., Ltd. 021-64340559 13651849907;
xinyu_shi@jwypharmlab.com.cn China 12036 58
Nantong puyue biomedical Co., Ltd 0513-0513-0513-89158300 18014392889
sales@puyerbiopharma.com China 4582 58
Shanghai Ruipu Medical Technology Co., Ltd 15895968936
1018762393@qq.com China 9996 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 13327728092
sales@pharmablock.com China 9699 58
Shanghai Haozhu Pharmaceutical Technology Co. , Ltd. 18912729622
66161984@qq.com China 873 58

  • CIS-ETHYL 2-(BOC-AMINO)CYCLOPROPANECARBOXYLATE
  • cis-2-Bocamino-cyclopropanecarboxylic acid ethyl ester
  • Cyclopropanecarboxylic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-, ethyl ester, (1R,2S)-rel-
  • ethyl cis-2-(tert-butoxycarbonylamino)cyclopropanecarboxylate
  • 1421676-91-6
Copyright 2019 © ChemicalBook. All rights reserved